Results 211 to 220 of about 969,568 (244)
Some of the next articles are maybe not open access.

Pharmaceutical care

Pharmacy World and Science, 1996
Drug-treatment failures can be prevented by applying a Pharmaceutical Care system. Therapeutic outcome monitoring is such a system, which can be applied to the (drug) treatment of several diseases like asthma, diabetes and cardiovascular diseases. Pharmaceutical Care is an outcome oriented, cooperative, systematic approach to providing drug therapy ...
openaire   +2 more sources

Pharmaceutical Proteomics

Annals of the New York Academy of Sciences, 2000
Abstract: Genomics and proteomics are today well established in drug discovery and, in combination with combinatorial chemistry and high‐throughput screening, are helping to bring forward an unprecedented number of potential lead compounds. To avoid the generation of bottlenecks downstream in drug development, increasing pressure is arising to ...
S, Steiner, N L, Anderson
openaire   +2 more sources

Pharmaceutical counterfeiting

The Analyst, 2005
Pharmaceutical counterfeiting is becoming a serious problem both in developed and developing countries. This paper considers the extent of the problem and provides several examples of drugs which have been counterfeited. Additionally, the effects of counterfeit products on consumers, health care providers, drug manufacturers and governments are ...
openaire   +2 more sources

Protein pharmaceuticals

Drug Discovery Today: Technologies, 2008
Udgivelsesdato ...
Van De Weert, Marco, Møller, Eva Horn
openaire   +3 more sources

Radioactive pharmaceuticals

Clinical Pharmacology & Therapeutics, 1963
Diagnostic radiopharmaceuticals are administered to provide information rather than to induce pharmacologic response. Therefore, one cannot translate pharmacologic principles established for stable compounds directly to radioactive compounds. If radioactive materials are to be used safely and effectively, certain principles must be followed.
openaire   +2 more sources

Mitochondrial pharmaceutics

Mitochondrion, 2004
Since the end of the 1980s, key discoveries have been made which have significantly revived the scientific interest in a cell organelle, which has been studied continuously and with steady success for the last 100 years. It has become increasingly evident that mitochondrial dysfunction contributes to a variety of human disorders, ranging from ...
Volkmar, Weissig   +2 more
openaire   +2 more sources

Pharmaceutical Excipients

Neonatal Network, 2000
WHY IS THE USE OF SINGLE-DOSE vials the norm in the NICU? Why is preservative-free parenteral solution standard care in the NICU? The simple response is that neonates are not just small adults. Children, especially neonates, differ from adults in their drug pharmacokinetics (absorption, distribution, metabolism, elimination).
openaire   +2 more sources

Green Pharmaceuticals

2015
The contextualization of the general issue of environmental contamination with psychiatric pharmaceuticals, their metabolites and transformation products and the recognition of the huge effort, the spent energy and the investment needed to remediate the contaminated sites and systems, make us wonder why not avoid it in the first place? Green technology,
Silva, Bruna   +3 more
openaire   +2 more sources

Pharmaceutical Analysis

ELECTROPHORESIS, 2018
Gerhard, Scriba, Hermann, Wätzig
openaire   +2 more sources

Home - About - Disclaimer - Privacy